These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. New South Wales annual vaccine-preventable disease report, 2012. Rosewell A; Spokes P; Gilmour R Western Pac Surveill Response J; 2014; 5(2):15-22. PubMed ID: 25077033 [TBL] [Abstract][Full Text] [Related]
10. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. Papania MJ; Wallace GS; Rota PA; Icenogle JP; Fiebelkorn AP; Armstrong GL; Reef SE; Redd SB; Abernathy ES; Barskey AE; Hao L; McLean HQ; Rota JS; Bellini WJ; Seward JF JAMA Pediatr; 2014 Feb; 168(2):148-55. PubMed ID: 24311021 [TBL] [Abstract][Full Text] [Related]
11. Impact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014. Thompson C; Dey A; Fearnley E; Polkinghorne B; Beard F Vaccine; 2017 Jan; 35(1):170-176. PubMed ID: 27876203 [TBL] [Abstract][Full Text] [Related]
12. Measles control in Australia - threats, opportunities and future needs. MacIntyre CR; Kpozehouen E; Kunasekaran M; Harriman K; Conaty S; Rosewell A; Druce J; Martin N; Heywood AE; Gidding HF; Wood J; Nicholl S Vaccine; 2018 Jul; 36(30):4393-4398. PubMed ID: 29934234 [TBL] [Abstract][Full Text] [Related]
13. A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study. Westphal DW; Eastwood A; Levy A; Davies J; Huppatz C; Gilles M; Lyttle H; Williams SA; Dowse GK Lancet Infect Dis; 2019 Feb; 19(2):177-184. PubMed ID: 30558994 [TBL] [Abstract][Full Text] [Related]
14. Measles in Europe: an epidemiological assessment. Muscat M; Bang H; Wohlfahrt J; Glismann S; Mølbak K; Lancet; 2009 Jan; 373(9661):383-9. PubMed ID: 19131097 [TBL] [Abstract][Full Text] [Related]
15. Classification of global measles cases in 2013-17 as due to policy or vaccination failure: a retrospective review of global surveillance data. Patel MK; Orenstein WA Lancet Glob Health; 2019 Mar; 7(3):e313-e320. PubMed ID: 30784632 [TBL] [Abstract][Full Text] [Related]
16. Achieving measles elimination and emerging modified measles: Longitudinal measles epidemiology from 1982 to 2021 in Osaka Prefecture, Japan. Kurata T; Kaida Y; Kanbayashi D; Motomura K Vaccine; 2024 Jan; 42(2):271-286. PubMed ID: 38097458 [TBL] [Abstract][Full Text] [Related]
17. Measles elimination and immunisation: national surveillance trends in Japan, 2008-2015. Inaida S; Matsuno S; Kobune F Epidemiol Infect; 2017 Aug; 145(11):2374-2381. PubMed ID: 28641590 [TBL] [Abstract][Full Text] [Related]
18. Surveillance and vaccination coverage of measles and rubella in Northern Italy. Amendola A; Bubba L; Piralla A; Binda S; Zanetti A; Pariani E; Ranghiero A; Premoli M; Pellegrinelli L; Coppola L; Gramegna M; Baldanti F; Zanetti A Hum Vaccin Immunother; 2015; 11(1):206-13. PubMed ID: 25483537 [TBL] [Abstract][Full Text] [Related]
19. A Comparison of Postelimination Measles Epidemiology in the United States, 2009-2014 Versus 2001-2008. Fiebelkorn AP; Redd SB; Gastañaduy PA; Clemmons N; Rota PA; Rota JS; Bellini WJ; Wallace GS J Pediatric Infect Dis Soc; 2017 Mar; 6(1):40-48. PubMed ID: 26666559 [TBL] [Abstract][Full Text] [Related]